Yes, Analgesics Can Worsen Migraines Through Medication Overuse Headache
Overuse of analgesics and anti-migraine medications directly causes medication overuse headache (MOH), transforming episodic migraine into chronic daily headache. This is a well-established phenomenon where the very medications used to treat migraine attacks paradoxically increase headache frequency when used too frequently 1.
Understanding Medication Overuse Headache
MOH is defined as headache occurring on ≥15 days per month for at least 3 months in someone with a pre-existing headache disorder, developing because of medication overuse 1. The critical thresholds vary by medication class:
- NSAIDs and acetaminophen: ≥15 days per month
- Triptans, ergots, opioids, or combination analgesics: ≥10 days per month 1
The prevalence of MOH in the general population is 0.7-1%, with higher rates in women and those with comorbid mental disorders 2.
Risk Varies by Medication Class
Not all analgesics carry equal risk for causing MOH. The evidence shows a clear hierarchy:
Highest Risk Medications:
- Opioids and analgesics carry the greatest risk of MOH 3
- Combination analgesics (e.g., butalbital-containing compounds) are particularly problematic 1
- Simple analgesics (NSAIDs, acetaminophen) have intermediate risk 3
Lower Risk Medications:
- Triptans show 35% lower relative risk compared to analgesics 3
- Ergots demonstrate 59% lower relative risk compared to analgesics 3
- Both triptans and ergots show substantially lower risk compared to opioids (65% and 24% reduction respectively) 3
Why Migraine Patients Are Particularly Vulnerable
Migraine patients demonstrate a stronger psychological link to their analgesic medications compared to patients with other chronic pain conditions (such as rheumatic disease), making them more susceptible to overuse 4. The association between analgesic overuse and chronic headache is 10 times stronger for chronic migraine than for chronic neck or back pain 5.
Importantly, individuals with a history of migraine are predisposed to developing chronic daily headache when using analgesics regularly—even when those analgesics are prescribed for non-headache conditions 6. In one study, regular analgesic use for arthritis preceded the onset of daily headache by an average of 5.4 years in migraine patients 6.
Clinical Implications and Prevention
The key to preventing MOH is early identification and patient education 7, 1:
Use a headache diary to track medication frequency and identify overuse patterns 7
Counsel patients at treatment initiation about MOH risk and frequency thresholds 1
Avoid opioids and butalbital entirely for acute migraine treatment—these should not be used 1
Prefer migraine-specific treatments (triptans, gepants) over simple analgesics when appropriate, as they carry lower MOH risk 3
Consider preventive therapy early if acute treatment is needed frequently, rather than allowing continued escalation of acute medication use 7, 1
Treatment Algorithm When MOH Develops
When MOH is identified, treatment follows three steps 2:
- Patient education and counseling with the goal of reducing acute medication intake
- Initiate headache prophylaxis with topiramate, amitriptyline, or onabotulinumtoxin A
- If these fail, implement a drug holiday (medication withdrawal), which can be done in outpatient, day clinic, or inpatient settings depending on severity and comorbidities
The evidence clearly demonstrates that analgesics worsen migraines through a dose-dependent mechanism, with certain medication classes (particularly opioids and combination analgesics) posing the highest risk. Migraine patients are uniquely vulnerable to this phenomenon compared to other chronic pain populations.